In addition, anti-AT1R and anti-ETAR are considered the main non-HLA antibodies involved in allograft transplant rejection, which is an intriguing point considering that graft versus host disease (GVHD) shares several similarities with scleroderma [17]. Here, EDNRA is linked to graft versus host disease.